A case of airway hemangioma in a 1-month-old infant with dyspnea
10.4168/aard.2022.10.1.50
- Author:
Hyo-Bin KIM
1
;
Sang-Hwa HONG
;
Hee-Won CHEUH
;
Jin-A JUNG
Author Information
1. Department of Pediatrics, Dong-A University College of Medicine, Busan, Korea
- Publication Type:CASE REPORT
- From:Allergy, Asthma & Respiratory Disease
2022;10(1):50-54
- CountryRepublic of Korea
- Language:English
-
Abstract:
Infantile hemangiomas are the most common benign tumors of infancy. However, hemangiomas located in the respiratory tract are rare and could cause life-threatening events due to airway obstruction. To date, the best recommended treatment for infantile hemangioma is oral propranolol because it demonstrates faster effects and fewer adverse effects than systemic corticosteroid therapy. Here, we report a case of a 1-month-old girl who presented with respiratory symptoms and hemangioma on the scalp. The hemangioma extended from the right base of the skull to thoracic inlet, causing inspiratory stridor and dyspnea. Treatment with oral propranolol was initiated and her symptoms regressed. Imaging showed regression of the hemangioma. This is a rare case of skin hemangioma found on the scalp, in which the hemangioma extended from the base of the skull to the subglottis, precipitating respiratory symptoms from airway obstruction. Based on this encounter, the presentation of skin hemangioma on the head, coupled with respiratory symptoms, necessitates the use of imaging studies, such as computed tomography, ultrasound, and magnetic resonance imaging to ascertain the extent of hemangioma.
